Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (49)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by PERSSON, I.
Right arrow Articles by ADAMI, H.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PERSSON, I.
Right arrow Articles by ADAMI, H.-O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Reliability of Women's Histories of Climacteric Oestrogen Treatment Assessed by Prescription Forms

INGEMAR PERSSON, LEIF BERGKVIST and HANS-OLOV ADAMI

Departments of Gynaecology and Obstetrics and Surgery, University Hospital S-751 85 UPPSALA, Sweden

A questionnaire study conducted in a cohort of women who had been prescribed oestrogen treatment for climacteric symptoms provided a unique opportunity to assess the concordance between their histories of oestrogen use and the exposure data derived from the prescription forms that had been collected for recruitment of the cohort. The questionrraire information, which was gathered within three years after the registration of prescription forms, was found to be highly concordant with the prescription data with respect to name of brand (85%), dosage (88%), treatment schedule—cyclic versus continuous—(88%), total duration of drug intake (months of treatment; correlation coefficient 0.98) and time of start of medication (correct month in 85%). A method for estimating the true exposure on the basis of prescription data—taking into account non-compliance and non-registered forms—was developed and found to be reproducible. It was concluded that information on climacteric oestrogen intake could be reliably obtained through a questionnaire within a period of less than three years after the exposure.

Revised 1 February 1986


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. I. Li, K. E. Malone, P. L. Porter, T. J. Lawton, L. F. Voigt, K. L. Cushing-Haugen, M. G. Lin, X. Yuan, and J. R. Daling
Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 43 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
B. L. Strom, R. Schinnar, A. L. Weber, G. Bunin, J. A. Berlin, M. Baumgarten, A. DeMichele, S. C. Rubin, M. Berlin, A. B. Troxel, et al.
Case-Control Study of Postmenopausal Hormone Replacement Therapy and Endometrial Cancer
Am. J. Epidemiol., October 15, 2006; 164(8): 775 - 786.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. Glud, S. K. Kjaer, B. L. Thomsen, C. Hogdall, L. Christensen, E. Hogdall, J. E. Bock, and J. Blaakaer
Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer
Arch Intern Med, November 8, 2004; 164(20): 2253 - 2259.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
D. M. Boudreau, J. R. Daling, K. E. Malone, J. S. Gardner, D. K. Blough, and S. R. Heckbert
A Validation Study of Patient Interview Data and Pharmacy Records for Antihypertensive, Statin, and Antidepressant Medication Use among Older Women
Am. J. Epidemiol., February 1, 2004; 159(3): 308 - 317.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. I. Li, K. E. Malone, P. L. Porter, N. S. Weiss, M.-T. C. Tang, K. L. Cushing-Haugen, and J. R. Daling
Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer
JAMA, June 25, 2003; 289(24): 3254 - 3263.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
T. Riman, P. W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C. M. Magnusson, and I. R. Persson
Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study
Am. J. Epidemiol., August 15, 2002; 156(4): 363 - 373.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
T. Riman, P. W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C. M. Magnusson, E. Weiderpass, and I. R. Persson
Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women
J Natl Cancer Inst, April 3, 2002; 94(7): 497 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
L. Lipworth, J. P Fryzek, C M. Fored, W. J Blot, and J. K McLaughlin
Comparison of surrogate with self-respondents regarding medical history and prior medication use
Int. J. Epidemiol., April 1, 2001; 30(2): 303 - 308.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
I. C. D. Westendorp, B. A. I.’t Veld, M. L. Bots, J. M. Akkerhuis, A. Hofman, D. E. Grobbee, and J. C. M. Witteman
Hormone Replacement Therapy and Intima-Media Thickness of the Common Carotid Artery : The Rotterdam Study
Stroke, December 1, 1999; 30(12): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.